Evolocumab in LDL-C Reduction
from MediBeez Podcast Hosted by MediBeez Podcast
Results from a landmark European HEYMANS study show that Evolocumab treatment has demonstrated the capacity to influence substantial reductions in LDL-C levels for an extended duration. To delve deeper into the details, listen to this podcast now.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of MediBeez Podcast?
This episode is 4 minutes long.
When was this MediBeez Podcast episode published?
This episode was published on December 15, 2023.
Can I download this MediBeez Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.